CMS has indeed delayed the implementation date for the Skin Substitute Grafts/ Cellular and Tissue-Based Products (CTP) for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers LCDs from 2/12/25 to 4/13/25. The policies on the CMS website are now “future effective.” The link above is as an example of one of the LCDs, and if you scroll to the end of the LCD, it will state the future effective date of 4/13/25. This applies to all of the MACs LCDs and Coding and Billing Articles.
This is what is at the end of the LCD:
Related Local Coverage Documents
Articles
- A57680 – Billing and Coding: Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers (Future)
- A59824 – Response to Comments: Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers
LCDs
Related National Coverage Documents
N/A
Public Versions
|
Updated On |
Effective Dates |
Status |
|
|
11/08/2024 |
04/13/2025 – N/A |
Future Effective |
You are here |
|
11/21/2019 |
01/08/2019 – 02/11/2025 |
Currently in Effect |
|
|
Some older versions have been archived. Please visit the MCD Archive Site to retrieve them. |
|||
–Caroline
Dr. Fife is a world renowned wound care physician dedicated to improving patient outcomes through quality driven care. Please visit my blog at CarolineFifeMD.com and my Youtube channel at https://www.youtube.com/c/carolinefifemd/videos
The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.
